Richard A. Richieri - Jan 9, 2024 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role
Chief Operations Officer
Signature
/s/ Stephen Hedberg, by Power of Attorney for Richard A. Richieri
Stock symbol
CDMO
Transactions as of
Jan 9, 2024
Transactions value $
-$7,225
Form type
4
Date filed
1/11/2024, 07:38 PM
Previous filing
Jan 3, 2024
Next filing
Apr 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +507 +2.1% 24.7K Jan 9, 2024 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise +945 +3.83% 25.6K Jan 9, 2024 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise +1.06K +4.14% 26.7K Jan 9, 2024 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale -$6.51K -1.06K -3.95% $6.17 25.6K Jan 10, 2024 Direct F2, F3
transaction CDMO Common Stock, $0.001 par value Options Exercise +40 +0.79% 5.11K Jan 9, 2024 By Spouse F1
transaction CDMO Common Stock, $0.001 par value Options Exercise +83 +1.62% 5.19K Jan 9, 2024 By Spouse F1
transaction CDMO Common Stock, $0.001 par value Options Exercise +132 +2.54% 5.32K Jan 9, 2024 By Spouse F1
transaction CDMO Common Stock, $0.001 par value Sale -$716 -116 -2.18% $6.17 5.21K Jan 10, 2024 By Spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -507 -1.5% $0.00 33.4K Jan 9, 2024 Common Stock 507 Direct F1, F4
transaction CDMO Restricted Stock Units Options Exercise $0 -945 -2.83% $0.00 32.4K Jan 9, 2024 Common Stock 945 Direct F1, F5
transaction CDMO Restricted Stock Units Options Exercise $0 -1.06K -3.27% $0.00 31.4K Jan 9, 2024 Common Stock 1.06K Direct F1, F6
transaction CDMO Restricted Stock Units Options Exercise $0 -40 -1.21% $0.00 3.26K Jan 9, 2024 Common Stock 40 By Spouse F1, F4
transaction CDMO Restricted Stock Units Options Exercise $0 -83 -2.54% $0.00 3.18K Jan 9, 2024 Common Stock 83 By Spouse F1, F5
transaction CDMO Restricted Stock Units Options Exercise $0 -132 -4.15% $0.00 3.05K Jan 9, 2024 Common Stock 132 By Spouse F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 Represents the shares automatically sold by the reporting person and/or the reporting person's spouse pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4, 5 and 6. This sale does not represent a discretionary trade.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $6.14 to $6.205. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
F5 RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
F6 RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.